Clinical trial
Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular…
NCT00198445 · Bausch & Lomb Incorporated, Industry · Completed
Key facts
| NCT number | NCT00198445 |
|---|---|
| Title | Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract Surgery |
| Official title | Efficacy and Safety of Topical Bromfenac Ophthalmic Solution, 0.1% vs. Placebo for Treatment of Ocular Inflammation Following Cataract Surgery |
| Lead sponsor | Bausch & Lomb Incorporated, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Postoperative Complications, Cataract |
| Intervention type | Drug |
| Interventions | Bromfenac, Placebo |
| Enrollment | 527 |
| Start date | May 1, 2003 |
| Primary completion | Jan 1, 2004 |
| Completion | Jan 1, 2004 |
| First posted | Sep 20, 2005 |
| Last update posted | Mar 14, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: